About the Department of Neurology

• 
• 
• 
• 
• 
• 
• 
• One of our resident training sites.
• 
• 
• 
• 
• One of our resident training sites.
• 
• One of our resident training sites.

Neurology in the Media

New Drugs That Block a Brain Chemical Are Game Changers for Some Migraine Sufferers

Richard Lipton, M.D., discusses the use of a newer class of migraine drugs known as gepants, which target a neurotransmitter implicated in migraine. Dr. Lipton is Edwin S. Lowe Professor and vice chair of the Saul R. Korey Department of Neurology at Einstein, and director of the Montefiore Headache Center.

The Science of Migraines

Dawn Buse, Ph.D., describes the triggers and phases of migraines and explains that a variety of treatments are available to people who suffer from the debilitating headaches. Dr. Buse is clinical professor in the Saul R. Korey Department of Neurology.

coverage on other stories

Related Einstein News

• Linking Sensory and Motor Abilities in Diabetes
  Posted: Friday, March 26, 2021
• A Better Way to Analyze Single-Cell Sequencing Data
  Posted: Thursday, March 25, 2021
• Gaining Insights into Huntington's Disease
  Posted: Friday, February 12, 2021

read more

• p

  	Video

• 	The Doctor’s Tablet Blog

• 	Subscribe